Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?: A Multivariable Analysis
暂无分享,去创建一个
M E Moseley | C. Beaulieu | M. Moseley | G. Albers | M. Lansberg | M. Marks | V. Thijs | G W Albers | M P Marks | C Beaulieu | V N Thijs | M G Lansberg
[1] W. Koroshetz,et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. , 1999, Stroke.
[2] N. Wahlgren,et al. Clomethiazole Acute Stroke Study (CLASS) Results of a Randomized, Controlled Trial of Clomethiazole Versus Placebo in 1360 Acute Stroke Patients , 1998 .
[3] E. Tolosa,et al. Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. , 1995, Stroke.
[4] Xin Qun Wang,et al. A predictive risk model for outcomes of ischemic stroke. , 2000, Stroke.
[5] T. Brott,et al. Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.
[6] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.
[7] M. Naeser,et al. Quantitative CT scan studies in aphasia I. Infarct size and CT numbers , 1981, Brain and Language.
[8] B. Cesana,et al. Prognostic Factors in First‐Ever Stroke in the Carotid Artery Territory Seen Within 6 Hours After Onset , 1993, Stroke.
[9] L H Schwamm,et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. , 1998, Stroke.
[10] J. Woo,et al. Dichotomizing stroke outcomes based on self-reported dependency , 1997, Neurology.
[11] R. Temple,et al. Are surrogate markers adequate to assess cardiovascular disease drugs? , 1999, JAMA.
[12] M. Moseley,et al. Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. , 2000, Archives of neurology.
[13] H. Ellis. stroke , 1997, The Lancet.
[14] W. Mali,et al. Diffusion-weighted magnetic resonance imaging in acute stroke. , 1998, Stroke.
[15] T. S. Olsen. Outcome following occlusion of the middle cerebral artery , 1991, Acta neurologica Scandinavica.
[16] K. Muir,et al. Neuroprotection for acute stroke: making clinical trials work. , 1999, Stroke.
[17] C. Beaulieu,et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome , 1999, Annals of neurology.
[18] Multicentre Acute Stroke Trial—Italy Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke , 1995, The Lancet.
[19] M Fisher,et al. New magnetic resonance techniques for acute ischemic stroke. , 1995, JAMA.
[20] J. Zivin. Diffusion‐weighted MRI for diagnosis and treatment of ischemic stroke , 1997, Annals of neurology.
[21] P D Lyden,et al. Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. , 1999, Stroke.
[22] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[23] V. L. Doyle,et al. Middle Cerebral Artery Territory Infarction Spectroscopy and Initial Infarct Volume by MRI Predicts Outcome in Patients With Acetyl Aspartate Concentration by Magnetic Resonance N-Measurement of Initial , 1999 .
[24] Gottfried Schlaug,et al. Ischemic lesion volumes in acute stroke by diffusion‐weighted magnetic resonance imaging correlate with clinical outcome , 1997, Annals of neurology.
[25] F. Mahoney,et al. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.
[26] B T Volpe,et al. Middle cerebral artery stroke that includes the premotor cortex reduces mobility outcome. , 1999, Stroke.
[27] P. Dorman,et al. The influence of baseline prognostic variables on outcome after thrombolysis , 1999, Journal of Neurology.
[28] S. Warach,et al. A randomized dose-response trial of citicoline in acute ischemic stroke patients , 1997, Neurology.
[29] R J Seitz,et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. , 1999, Stroke.
[30] W R Clarke,et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.
[31] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[32] J Bamford,et al. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. , 1987, Stroke.
[33] L. Jongbloed. Prediction of function after stroke: a critical review. , 1986, Stroke.
[34] C. Aring,et al. A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.
[35] F. I. Mahonery. Functional evaluation : Barthel index , 1965 .
[36] V. Hachinski,et al. Prognosis of acute stroke , 1987, Neurology.
[37] D. Saunders,et al. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction. , 1995, Stroke.
[38] R R Edelman,et al. Clinical Outcome in Ischemic Stroke Predicted by Early Diffusion-Weighted and Perfusion Magnetic Resonance Imaging: A Preliminary Analysis , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] T Brott,et al. Measurements of acute cerebral infarction: lesion size by computed tomography. , 1989, Stroke.
[40] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[41] G. Schroth,et al. [Diffusion-weighted imaging in acute stroke]. , 1998, Der Nervenarzt.
[42] S M Davis,et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI , 1998, Neurology.
[43] G. Schlaug,et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.
[44] H. Diener,et al. Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. , 2000, Stroke.
[45] M. Moseley,et al. Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients , 2000, Neurology.
[46] R R Edelman,et al. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke , 1997, Neurology.
[47] J. Kucharczyk,et al. Early detection of regional cerebral ischemia in cats: Comparison of diffusion‐ and T2‐weighted MRI and spectroscopy , 1990, Magnetic resonance in medicine.
[48] G. Albers,et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. , 1999, JAMA.
[49] Granger Cv,et al. Stroke rehabilitation: analysis of repeated Barthel index measures. , 1979, Archives of physical medicine and rehabilitation.
[50] L. Munari,et al. RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE , 1995 .
[51] S. Warach,et al. Magnetic Resonance Imaging of Acute Stroke , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.